Reuters logo
BRIEF-Juvéderm Vollure XC approved by FDA for correction of facial wrinkles and folds
March 20, 2017 / 11:38 AM / 6 months ago

BRIEF-Juvéderm Vollure XC approved by FDA for correction of facial wrinkles and folds

March 20 (Reuters) - Allergan Plc:

* Juvéderm Vollure™ XC approved by U.S. FDA for correction of facial wrinkles and folds in adults over the age of 21

* Allergan- Received approval from U.S. FDA to market Juvéderm Vollure XC, for correction of facial wrinkles and folds in adults over age of 21 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below